SyncoZymes (Shanghai) Co., Ltd. – Trademark Portfolio
Entity Type: 16
SyncoZymes (Shanghai) Co., Ltd. holds 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 3 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 2 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include SIRTALITY and SYNCOZYMES. The owner is based in Shanghai.
Pudong New District
No. 1199 Landian Road
Shanghai 201318 , CN
Showing of trademarks Trademarks
Trademark Classifications
SyncoZymes (Shanghai) Co., Ltd.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Scientific and technological services; industrial analysis and research services
Frequently Asked Questions
How many trademarks does SyncoZymes (Shanghai) Co., Ltd. have?
SyncoZymes (Shanghai) Co., Ltd. has 4 U.S. trademarks filed with the USPTO. Of these, 2 registered, 2 abandoned.
What trademark classes does SyncoZymes (Shanghai) Co., Ltd. file in?
SyncoZymes (Shanghai) Co., Ltd. files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are SyncoZymes (Shanghai) Co., Ltd.'s most well-known trademarks?
SyncoZymes (Shanghai) Co., Ltd.'s registered trademark portfolio includes well-known marks such as SIRTALITY and SYNCOZYMES. These are among 2 currently registered trademarks in the portfolio.
What is SyncoZymes (Shanghai) Co., Ltd.'s trademark registration success rate?
SyncoZymes (Shanghai) Co., Ltd. has a 50% trademark registration rate, with 2 out of 4 resolved applications resulting in successful registration. Currently, 0 applications are pending review.